Proteros Enters into a Collaboration with Bayer
News Jan 10, 2015
Proteros biostructures GmbH has announced that they have entered into a drug discovery research collaboration with Bayer Pharma AG (Bayer). The objective of the collaboration is to identify novel compounds for the treatment of cardiovascular diseases.
Discovery efforts on an undisclosed regulatory membrane protein will be driven by Proteros over a 2 year period to meet predefined milestones, while Bayer would be responsible for further preclinical candidate optimization and clinical development.
Proteros will receive R&D funding, downstream milestones, and royalties on sales of potential resulting commercial products.
The program is based on Proteros´ structure-guided lead discovery platform which combines structure analysis, medicinal chemistry and other discovery technologies to drive potency, selectivity, and safety of novel lead compounds.
Dr. Peter Reinemer, COO of Proteros, commented: “Regulatory membrane proteins are among the most challenging class of targets for structure guided drug discovery approaches. We are very pleased to partner with Bayer in this important initiative for potential new drug candidates for cardiovascular diseases”.
Elpis BioMed Closes Funding Round to Commercialise Novel Technology Platform for Generating Human Cell TypesNews
New Cambridge spin-out company commercialises disruptive technology that enables rapid generation of pure and consistent batches of human cell types. Geographically diversified, top-tier investor team includes key industry leaders to support early company development.READ MORE
Quotient Sciences Acquires Pharmaterials, a UK-based Contract Development and Manufacturing OrganizationNews
Quotient Sciences, the drug development services organization, announces it has acquired Pharmaterials, a contract development and manufacturing organization (CDMO) based in Reading, U.K..READ MORE
BOC Sciences Continues to Enlarge Its Publication Collection Using BOC Sciences ProductsNews
BOC Sciences continues to add more publication items that used BOC Sciences products in their researches to its already existing collection.READ MORE